JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4751
FT Vest Fund of Buffer ETFs
BUFR
$10.9B
| $231K | ﹤0.01% |
9,830
+5,658
| +136% | +$130K |
2022 Q4
1 quarter
|
|
|
EBTC
4752
DELISTED
Enterprise Bancorp
EBTC
| $230K | ﹤0.01% |
7,301
+54
| +0.7% | +$1.86K |
2017 Q4
21 quarters
|
|
|
FLIC
4753
DELISTED
First of Long Island Corp
FLIC
| $230K | ﹤0.01% |
17,016
-2,543
| -13% | -$42.6K |
2013 Q2
39 quarters
|
|
4754
PLAYSTUDIOS Inc
MYPS
$55M
| $230K | ﹤0.01% |
6,232
+1,547
| +33% | +$62.6K |
2022 Q2
3 quarters
|
|
4755
Amplify Energy
AMPY
$186M
| $229K | ﹤0.01% |
33,344
+7,352
| +28% | +$60.4K |
2017 Q2
23 quarters
|
|
|
SABA
4756
Saba Capital Income & Opportunities Fund II
SABA
$210M
| $229K | ﹤0.01% |
26,054
+24,691
| +1,812% | +$214K |
2022 Q4
1 quarter
|
|
4757
ProShares Nanotechnology ETF
TINY
$14.2M
| $229K | ﹤0.01% |
6,635
-6,782
| -51% | -$220K |
2021 Q4
5 quarters
|
|
4758
iShares Dow Jones US ETF
IYY
$3.09B
| $228K | ﹤0.01% |
2,277
+588
| +35% | +$57.5K |
2013 Q2
39 quarters
|
|
4759
Cullinan Oncology
CGEM
$1.05B
| $228K | ﹤0.01% |
22,243
+2,858
| +15% | +$31.5K |
2021 Q1
8 quarters
|
|
4760
HUTCHMED
HCM
$2.54B
| $228K | ﹤0.01% |
17,499
-5,503
| -24% | -$90.2K |
2017 Q2
23 quarters
|
|
4761
Century Therapeutics
IPSC
$239M
| $228K | ﹤0.01% |
65,752
+291
| +0.4% | +$1.28K |
2021 Q3
6 quarters
|
|
4762
Nano X Imaging
NNOX
$48.4M
| $228K | ﹤0.01% |
39,592
+9,594
| +32% | +$73.3K |
2020 Q4
9 quarters
|
|
|
TBLD
4763
Thornburg Income Builder Opportunities Trust
TBLD
$649M
| $228K | ﹤0.01% |
+14,599
| New | +$220K |
2023 Q1
0 quarters
|
|
|
KMF
4764
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
| $228K | ﹤0.01% |
29,711
+25,636
| +629% | +$192K |
2022 Q4
1 quarter
|
|
4765
Ranger Energy Services
RNGR
$366M
| $227K | ﹤0.01% |
+22,254
| New | +$243K |
2023 Q1
0 quarters
|
|
4766
Southern Missouri Bancorp
SMBC
$789M
| $227K | ﹤0.01% |
6,088
-270
| -4% | -$12.2K |
2017 Q4
21 quarters
|
|
4767
PUT
Take-Two Interactive
TTWO
$37.9B
| $227K | ﹤0.01% |
1,900
-2,100
| -53% | -$234K |
2021 Q1
8 quarters
|
|
|
LOMA
4768
Loma Negra
LOMA
$1.13B
| $226K | ﹤0.01% |
32,410
-11,451
| -26% | -$79.7K |
2020 Q4
9 quarters
|
|
4769
Schwab 1000 Index ETF
SCHK
$5.85B
| $225K | ﹤0.01% |
11,396
+3,878
| +52% | +$74.9K |
2022 Q3
2 quarters
|
|
4770
Bank7 Corp
BSVN
$530M
| $225K | ﹤0.01% |
9,164
+9,159
| +183,180% | +$252K |
2018 Q4
17 quarters
|
|
|
BHIL
4771
DELISTED
Benson Hill, Inc.
BHIL
| $225K | ﹤0.01% |
5,590
+380
| +7% | +$28.4K |
2021 Q3
6 quarters
|
|
|
KDNY
4772
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $225K | ﹤0.01% |
+9,700
| New | +$231K |
2023 Q1
0 quarters
|
|
4773
SIGA Technologies
SIGA
$236M
| $224K | ﹤0.01% |
38,920
-17,179
| -31% | -$115K |
2018 Q1
20 quarters
|
|
4774
The RealReal
REAL
$1.14B
| $223K | ﹤0.01% |
177,015
-10,071
| -5% | -$14.6K |
2019 Q2
15 quarters
|
|
4775
Shinhan Financial Group
SHG
$36.6B
| $223K | ﹤0.01% |
8,279
-4,671
| -36% | -$143K |
2013 Q3
38 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.